|
The ornamental design for a tablet, as shown and described.
|
|||||||||||||||||
FIG. 1 is a top plan view of a tablet showing our new design;
FIG. 2 is a bottom plan view thereof;
FIG. 3 is a front elevational view thereof;
FIG. 4 is a side elevational view thereof;
FIG. 5 is a top perspective view thereof; and,
FIG. 6 is a bottom perspective view thereof.
Chen, Tzyy-Show H., Ikeda, Craig B.
| Patent | Priority | Assignee | Title |
| D553733, | Apr 07 2006 | Novartis AG | Tablet |
| D735315, | Jun 25 2012 | Amgen Inc | Pharmaceutical tablet |
| D744635, | Jun 26 2014 | Access Business Group International LLC | Dietary supplement |
| D754840, | Feb 03 2012 | JOHNSON & JOHNSON CONSUMER INC | Oral dosage form |
| D754841, | Feb 03 2012 | JOHNSON & JOHNSON CONSUMER INC | Oral dosage form |
| D755949, | Jul 30 2013 | RB HEALTH US LLC | Tablet |
| D778428, | Feb 03 2012 | JOHNSON & JOHNSON CONSUMER INC | Oral dosage form |
| D808110, | Jan 22 2015 | SOREMARTEC S A | Confectionery product |
| D813372, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
| D835257, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
| D835258, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
| D858741, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
| D907760, | Jan 20 2017 | SOCIÉTÉ DES PRODUITS NESTLÉ S A | Orally ingestible tablet |
| Patent | Priority | Assignee | Title |
| 2687367, | |||
| 4693886, | Apr 22 1985 | ALZA Corporation | Osmotic device with inert core |
| 4713248, | Feb 10 1984 | NYCOMED DANMARK A S | Diffusion coated multiple-units dosage form |
| 4851228, | Jun 20 1984 | MERCK & CO , INC , A CORP OF NJ | Multiparticulate controlled porosity osmotic |
| 5424074, | Jun 20 1989 | Otsuka Pharmaceutical Co., Ltd. | Pharmaceutical composition for potassium supplementation |
| 5427798, | Aug 14 1992 | SMITHKLINE BEECHAM CORPORATION, A PENNSYLVANIA CORPORATION | Controlled sustained release tablets containing bupropion |
| 5512299, | Mar 30 1992 | ALZA Corporation | Method of treating oral inflammatory disease |
| 5770225, | Apr 28 1989 | McNeil-PPC, Inc. | Process of preparing a subcoated simulated capsule-like medicament |
| 216307, | |||
| D258091, | Aug 31 1978 | Marion Laboratories, Inc. | Pharmaceutical tablet |
| D301764, | Dec 21 1987 | RHONE-POULENC RORER PHARMACEUTICALS INC | Pharmaceutical tablet |
| D302051, | Dec 21 1987 | RHONE-POULENC RORER PHARMACEUTICALS INC | Pharmaceutical tablet |
| D304626, | Dec 21 1987 | RHONE-POULENC RORER PHARMACEUTICALS INC | Pharmaceutical tablet |
| 31133, | |||
| D316914, | Aug 01 1989 | MERRELL DOW PHARMACEUTICALS LTD | Tablet |
| D351464, | Sep 29 1992 | Merck & Co., Inc. | Pharmaceutical product |
| D359554, | Dec 02 1991 | The Procter & Gamble Company | Tablet |
| D375157, | Dec 22 1992 | Merck Sharp & Dohme Corp | Tablet |
| D379223, | Sep 13 1995 | Merck Sharp & Dohme Corp | Pharmaceutical tablet |
| D380825, | Oct 31 1994 | Merck Sharp & Dohme Corp | Pharmaceutical tablet |
| D383535, | Apr 24 1996 | Schering Corporation | Tablet |
| D400672, | Mar 21 1996 | Merck Sharp & Dohme Corp | Pharmaceutical tablet |
| D423141, | Mar 20 1998 | Colgate-Palmolive Company | Detergent tablet |
| D428136, | Apr 28 1999 | Akzo Nobel N V | Bone shaped tablet |
| D431076, | Jul 07 1999 | Merck Sharp & Dohme Corp | Tablet |
| D434846, | Jul 07 1999 | Merck Sharp & Dohme Corp | Tablet |
| D459798, | Mar 26 2001 | AVENTIS PHARMA S A | Pill tablet |
| 56478, |
| Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
| Jul 09 2004 | CHEN, TZYY-SHOW H | MERCK & CO , INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 016611 | /0637 | |
| Jul 09 2004 | IKEDA, CRAIG B | MERCK & CO , INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 016611 | /0637 | |
| Jul 19 2004 | Merck & Co., Inc | (assignment on the face of the patent) | / | |||
| Nov 02 2009 | MERCK & CO , INC | Merck Sharp & Dohme Corp | CHANGE OF NAME SEE DOCUMENT FOR DETAILS | 023870 | /0001 | |
| Apr 26 2012 | Merck Sharp & Dohme Corp | Schering Corporation | MERGER SEE DOCUMENT FOR DETAILS | 028850 | /0515 | |
| May 02 2012 | Schering Corporation | Merck Sharp & Dohme Corp | CHANGE OF NAME SEE DOCUMENT FOR DETAILS | 028866 | /0511 |
| Date | Maintenance Fee Events |
| Date | Maintenance Schedule |